To assess the generalizability of TIMM23 knockdown across diverse NSCLC cell models, lentiviral delivery of shTIMM23-3 was employed in primary human NSCLC cells from distinct patients (pNSCLC-2 and pNSCLC-3, as reported early [26, 34, 35]) and the immortalized A549 cell line. This evidence concerns the gene TIMM23 and non-small cell lung carcinoma.